Members Area | Contact Us | Legal Notice | Search
Cobalt Development Institute
Promoting Cobalt Uses in All Forms
Home Page
The Institute
About Cobalt
Cobalt News
Cobalt Facts
Cobalt Abstract
World Patents
HS and E
REACH
REACH Consortium
Sustainability & LCA
Statistics
Conferences
Publications
News
Links
Members Directory
Recruitment
Contact Us


 

Patents - LIFE SCIENCES

1 2

Category list

January 2007
LIFE SCIENCES
WO 2006/098642 A1 (09/21/2006) Agresearch Limited
Munday R.
AGENT ADMINISTRATION
An intra-ruminal bolus is described that releases a therapeutically effective amount of at least one beneficial agent to a ruminant animal over a time period of less than approximately 21 days. The bolus is particularly useful for delivery of anti-parasitic compounds but may also be used for other active agents such as trace elements including selenium and cobalt.
WO 2006/082824 A1 (08/10/2006) NRL Pharma, Inc.
Kawano G, Seto I.
MATRIX-TYPE ENTERIC COATED SUSTAINED RELEASE COMPOSITION
A matrix-type enteric coated sustained release composition comprising a physiologically active substance, a gelling agent, a basic organic compound and an excipient; and other auxiliary components which contains one or more elements selected from the group consisting of an alkaline metal, an alkaline earth metal, manganese, cupper, iron, zinc and cobalt.
WO 2006/081142 A2 (08/03/2006) Exactech, Inc.
Terrill L.N.
PROSTHESIS INCLUDING A MECHANISM FOR ATTACHING A FIRST COMPONENT TO A SECOND COMPONENT
A prosthesis including a mechanism for attaching a first component eg femoral head component to a second component eg femoral stem component is provided. The femoral head component may comprise a ceramic material and the femoral stem component may comprise a metallic material (e.g., any desired orthopedic alloy, such as Cobalt Chromium etc).
WO 2006/054757 A1 (05/26/2006) Astellas Pharma Inc.
Nakada H, Maeomoto T, Muramatsu Y.
CASPASE INHIBITOR
A caspase inhibitor which contains, as the active ingredient, a cobalt porphyrin complex compound or a cobalt choline complex compound, enables caspase activity to be strongly and specifically inhibited. The caspase inhibitor and the cobalt porphyrin complex drugs are useful for preventing or treating various apoptosis-associated diseases.
July 2006
WO/2006/038202 A2 (04/13/2006) Politecnico Di Torino, Spriano, S.
Bugliosi, S.
Spriano S. Bugliosi S.
MEDICAL PROSTHETIC DEVICES PRESENTING ENHANCED BIOCOMPATIBILITY AND WEAR RESISTANCE, BASED ON COBALT ALLOYS AND PROCESS FOR THEIR PREPARATION
WO 2006/000823 A3 (03/23/2006) Oxford Biosensors Limited
Hyland M., Astier Y.
COMPOSITION AND ELECTROCHEMICAL SENSOR FOR DETECTING ISCHAEMIA
A2 published (01/05/2006)
WO 2006/014297 A1 (02/09/2006) Signase, Inc
Shaikh S. Budde R.
COBALT(II) COMPLEXES AS PROTEIN TYROSINE KINASE INHIBITORS
Various cobalt (II) complexes are able to selectively inhibit the protein tyrosine kinases (PTKs). These complexes are useful in the treatment of various diseases including hyperproliferative diseases, hematologic diseases, osteoporosis, neurological diseases, autoimmune diseases, allergic/immunological diseases, or viral infections.
WO 2005/073240 A3 (02/02/2006) Vysoká Skola Chemicko-Technologická V Praze, Ústav Organické Chemie A Biochemie Av Cz, Ústav Anorganické Chemie Av Cz, Department Of Virology, University Of Heidelberg
Král V. Cigler P. Konvalinka J. Kozísek M. Prejdová J. Grüner B. Plesek J. Lepsík M. Pokorná J. Kräusslich H-G. Bodem J.
NOVEL HIV PROTEASE INHIBITORS
Republished A3 previously published (08/11/05)
WO 2006/000823 A2 (01/05/2006) Oxford Biosensors Limited
Hyland M. Astier Y.
COMPOSITION AND ELECTROCHEMICAL SENSOR FOR DETECTING ISCHAEMIA
A composition suitable for use in an electrochemical detection of ischeamia via albumin cobalt finding test (ACB), comprises (i) a transition metal salt eg. Cobalt (II)
WO 2005/122773 A1 (12/29/2005) Mbec Bioproducts Inc.
Harrison J.J. Turner R.J. Ceri H.
THE USE OF HEAVY METALS IN THE TREATMENT OF BIOFILMS
A method of treating biofilms by exposure to heavy metals including cations such as manganese, cobalt, nickel, copper, zinc, aluminum, silver, mercury, lead, cadmium and tin
WO 2005/121068 A1 (12/22/2005) Degussa AG
Hateley M. Häussner T. Weckbecker C. Huthmacher K. Buss D.
PROCESS FOR PREPARING AMINO ACIDS USING THE AMIDOCARBONYLATION REACTION
The present invention relates to a sequence for the preparation of amino acids, for example alpha amino acids, in particular methionine, by making use of an amidocarbonylation reaction in the presence of a cobalt carbonyl catalyst and separating the catalyst in the form of a Co(N-amino acid)2 compound.
WO 2005/117762 A2 (12/15/2005) Biomedtrix, Inc.
Sidebotham C.G.
CANINE FEMORAL STEM SYSTEM
A canine femoral stem system provides a set of sizes of stems designed to fit in a reamed femoral bone canal with controlled interference. The stems can be implanted using either a cemented or cementless procedure, using cast cobalt chromium stems with 250 ± 50 µm beads of cobalt chromium.
WO 2005/107774 A1 (11/17/2005) ICIM International S.R.L.
Agostinini P.
PHARMACEUTICAL WOUND HEALING COMPOSITION
A pharmaceutical composition containing substantially one or more metals in ionic form such as Nickel, Cobalt, Cadmium, Iron, Chrome, Copper, Gold, Titanium, Zirconium and Molybdenum, and optionally Silver and/or Zinc, in an appropriate carrier is used for topical application as in the treatment of wounds and burns.
WO 2005/108309 A1 (11/17/2005) Garcia Gonzalez, José
Aguilar Camprubi M.M.
BIOLOGICAL TREATMENT WHICH CAN BE USED FOR BACTERIAL BIOREMEDIATION IN AQUATIC ECOSYSTEMS AND OF URBAN AND INDUSTRIAL EFFLUENTS IN ORDER TO ENSURE ADEQUATE DIGESTION OF ORGANIC MATTER AND NUTRIENTS
Bacterial bioremediation by applying a bacterial inoculum to water and adding a protein hydrolysate, circulating, then adding trace elements of iron, cobalt, zinc, nickel and molybdenum
WO 2005/073240 A3 (11/17/2005) Vysoká Skola Chemicko-Technologická V Praze, Ústav Organické Chemie A Biochemie Av Cz, Ústav Anorganické Chemie Av Cz, Department Of Virology, University Of Heidelberg
Král V. Cigler P. Konvalinka J. Kozísek M. Prejdová J. Grüner B. Plesek J. Lepsík M. Pokorná J. Kräusslich H-G. Bodem J.
NOVEL HIV PROTEASE INHIBITORS
A2 published (08/11/2005)
January 2006
WO 2005/093080 A2 (10/06/05) Degussa AG
Osswald S., Verseck S., Deiting U., Weckbecker C., Huthmacher K., Binder M., Kula M-R., Odendahl K.
NITRILE HYDRATASE OF RHODOCOCCUS
A polynucleotide cluster of rhodococcus containing nucleotide sequences coding for poly-peptides with the activity of a nitrile hydratase, an auxillary protein P15K activating the enzyme and a cobalt transporter. Micro-organisms transformed by the cluster in which the nucleotide sequences coding for the proteins are reinforced are used to produce amides from nitriles.
WO 2005/090592 A1 (09/22/05) Nikken Bio Medical Laboratory Inc.
Yamshoji S., Asakawa A.
METHOD OF HIGH-SENSITIVITY DETECTION OF MICROBE AND LUMINESCENCE MEASURING REAGENT KIT AND SYSTEM FOR MICROBE DETECTION
Microbial proliferation and/or activity is measured by incubating a microbe together with oxidised quinone in a culture solution and the product is reacted with a chemiluminescence reagent followed by quantitative determination. This reaction is carried out in the presence of ions of molybdenum, maganese, nickel or cobalt.
WO 2005/088297 A1 (09/22/05) Bloomsbury Innovations Ltd
Grossman S.I., Campbell J.G., Loane C.J.
APPARATUS FOR DETECTING GAMMA HYDROXYBUTYRATE, KETAMINES AND RELATED DRUGS IN BEVERAGES
method for detecting dopants in beverages eg ?-hydroxybutyrate, ketamines, etc. by colour reactions where cobalt nitrate, oxammonium chloride/ferric chloride, 5% ferric chloride, saturated potassium dichromate, toluene/cobalt thiocyanate, chromium (IV) oxide/sulphuric, etc. together with oxammonium salts and ferric chloride or lacmoid is supported on a substrate.
WO 2005/081842 University of Florida
Dempsey J.F.
SYSTEM FOR DELIVERING CONFORMAL RADIATION THERAPY WHILE SIMULTANEOUSLY IMAGING SOFT TISSUE
A device for performing high temporal- and spatial-resolution MR imaging of a patient during intensity modulated radiation therapy (IMRT0 to directly measure and control the highly conformal ionising radiation dose for the treatment of proliferative tissue disorders, includes cobalt teletherapy in a single co-registered and gantry mounted system.
WO 2005/082270 A1 (09/09/05) Parnell Laboratories (Aust) Pty Limited
Bell A.R., O'Connor G.N.
BOLUS FOR RUMINANT ANIMALS
A bolus for combatting trace element deficiency in a ruminant comprises a plurality of particles each of which comprises the trace element which and at least two components selected from the group consisting of a binder, a water soluble bulking agent, a water insoluble bulking agent and a disintegrating agent.
WO 2005/075979 A1 (08/18/05) Matsushita Electric Industrial Co. Ltd
Taniike Y., Miyashita M., Yoshioka T.
BIOSENSOR AND BIOSENSOR MEASURING DEVICE AND METHOD
A biosensor and a biosensor measuring device by which a user can judge the performance easily comprises a substrate having a quality judging section containing a cobalt salt moisture absorbing material which changes colour on absorbing moisture and a sample receiving section which has a reagent section containing an enzime.
WO 2005/073240 A2 (08/11/05) Vysoká Skola Chemicko-Technologická V Praze, Ustav Organické Chemie A Biochemie Av Cz, Ustav Anorganické Chemie Av Cz, Department of Virology, University of Heidelberg
Král V., Cigler P., Konvalinka J., Kozisek M., Prejdova J., Gruner B., Plesek J., Lepsik M., Pkorna J., Krausslich H-G., Bodem J.

Highly effective and stable novel HIV protease inhibitors containing 1 to 9 substituted borane, carborane or metallacarborane clusters with 6 to 12 boron atoms in each cluster, coordinated to transition metal atom eg cobalt, iron, nickel and ruthenium where the charge of each borane, carborane or metallacarborane cluster is 0, -1 or -2.
WO 2005/063042 A1 (07/14/05) Kao Corporation
Umdea T., Otsuji K.
PET FOOD
A pet food high in unsaturated fatty acids and of excellent long-term storage stability contains (A) 5050 wt% of fat or oil containing 5 mass% or more of diacylglycerol and 20 wt% of unsaturated fatty acids having two or more double bonds; (B) 0.001-1 wt% of copper, iron, manganese and cobalt and least 0.1 mass% of vitamin C derivative based on A.
WO 2005/051218 A3 (07/14/05) Ultradent Products, Inc.
Wagner J., Haschke E.
A2 published (06/09/05)
WO 2005/054498 A1 (06/16/05) Daikin Industries, Ltd
Fukui N., Akamatsu M.
METHOD F MEASURING MICROBE QUANTITY AND CULTURE MEDIUM FOR MICROBIAL EXPERIMENT
Microbes are counted by the oxygen electrode method. A solution containing cobalt phthalocyaninetetracarboxylic acid is used to dilute the sample to a given concentration provide a specimen solution. The sulfur compounds in the specimen are diffused into the diluent and adsorbed on the cobalt compound to eliminate its bacteriostatic action.

 

Home Page ... The Institute ... About Cobalt ... Cobalt News ... Cobalt Facts ... Cobalt Abstracts ... World Patents ...  
HS & E ... Statistics ... Conferences ... Publications ... News ... Links ... Members Directory ... Contact Us